| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 28,131 | 28,088 | 28,432 | 32,310 | | Cost of Revenue | 22,409 | 22,411 | 25,012 | 25,929 | | | Gross Profit | 5,722 | 5,677 | 3,420 | 6,381 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,372 | 4,103 | 4,389 | 4,825 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,350 | 1,574 | (969) | 1,556 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10 | 14 | 26 | 5 | | Earnings Before Interest And Taxes | 1,360 | 1,588 | (943) | 1,561 | | Interest Expense | 235 | 220 | 227 | 253 | | Income Before Tax | 1,124 | 1,368 | (1,170) | 1,307 | | Income Tax Expense | 217 | 526 | (88) | 268 | | Minority Interest |
-
|
-
|
-
| 28 | | | | Net Income From Continuing Ops | 907 | 842 | (1,083) | 1,068 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 907 | 842 | (1,083) | 1,068 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $907 | $842 | ($1,083) | $1,068 |
|
0.02% Nasdaq 
0.33%
Income Statement
